Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Helix
  4. Digital Avatars of Human Physiology

Digital Avatars of Human Physiology

Multiscale simulations forecasting intervention impacts.
Back to HelixView interactive version

Digital avatars of human physiology, also called 'biological twins' or 'virtual patients,' are comprehensive computational models that combine data from genomics, epigenetics, microbiome composition, lifestyle factors, and other sources into multiscale simulations that represent individual patients' physiology from the molecular to the whole-body level. These models allow researchers and clinicians to forecast how different interventions will affect individual patients before conducting human trials, enabling truly personalized medicine where treatments can be tested and optimized virtually before being administered. Companies and research institutions are developing these systems for applications in drug development and personalized medicine.

This innovation addresses the challenge of predicting how individual patients will respond to treatments, where current approaches rely on population averages that don't account for individual differences. By creating accurate models of individual patients, these systems enable personalized treatment planning and could reduce the need for extensive clinical trials. The technology is being developed for applications including drug development, treatment optimization, and personalized medicine.

The technology is particularly valuable for complex conditions where individual responses vary significantly, enabling truly personalized treatment approaches. As the technology improves and integrates more data sources, it could become a standard tool for personalized medicine. However, ensuring model accuracy, integrating diverse data sources, and validating predictions remain significant challenges. The technology represents an ambitious vision for personalized medicine, but requires substantial development to achieve the accuracy and reliability needed for clinical use. Success could transform healthcare by enabling truly personalized treatment planning, but the path to clinical adoption is long and requires careful validation and integration with clinical workflows.

TRL
4/9Formative
Impact
4/5
Investment
4/5
Category
Software

Related Organizations

Dassault Systèmes logo
Dassault Systèmes

France · Company

95%

Software corporation specializing in 3D design and digital mock-ups.

Developer
Virtual Physiological Human Institute logo
Virtual Physiological Human Institute

Belgium · Consortium

95%

An international non-profit organization promoting the Virtual Physiological Human (VPH).

Standards Body
Twin Health

United States · Startup

90%

Offers the 'Whole Body Digital Twin' service, using sensor data and AI to reverse chronic metabolic diseases like diabetes.

Developer
Unlearn.AI logo
Unlearn.AI

United States · Startup

90%

Creates 'Prognostic Digital Twins' of patients to populate control arms in clinical trials, reducing the need for placebo patients.

Developer
PrediSurge

France · Startup

85%

Develops digital twin software for endovascular interventions, simulating stent-graft deployment in patient-specific aortas.

Developer
Quris-AI

Israel · Startup

85%

Uses a 'Bio-AI' platform that combines organ-on-chip data with machine learning to predict drug safety in humans.

Developer
SimBioSys

United States · Startup

85%

Develops TumorScope, a platform that creates 3D digital twins of tumors to simulate response to surgical and drug interventions.

Developer
Linköping University logo
Linköping University

Sweden · University

80%

A public university in Linköping, Sweden.

Researcher
Virtonomy logo
Virtonomy

Germany · Startup

80%

Creates digital twins of patient anatomies to test medical devices virtually (v-Patients) before clinical trials.

Developer
Empa logo

Empa

Switzerland · Research Lab

75%

Swiss Federal Laboratories for Materials Science and Technology, researching self-healing elastomers.

Researcher

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Software
Software
Digital Twin Physiology Platforms

Patient-specific simulation stacks predicting therapy response.

TRL
5/9
Impact
5/5
Investment
4/5
Hardware
Hardware
Organ-on-Chip & Multi-Organ Microphysiological Systems

Microfluidic platforms simulating aging and rejuvenation pathways.

TRL
6/9
Impact
4/5
Investment
3/5
Software
Software
Adverse Event Prediction Systems

ML models flagging toxicity and safety issues during clinical trials.

TRL
6/9
Impact
5/5
Investment
4/5
Applications
Applications
Precision Longevity Interventions

Personalized stacks of therapeutics and lifestyle modifications.

TRL
7/9
Impact
4/5
Investment
4/5
Software
Software
In-Silico Longevity Drug Repurposing Engines

AI platforms identifying geroprotective properties in existing non-longevity drugs.

TRL
8/9
Impact
4/5
Investment
3/5
Ethics Security
Ethics Security
Consent & Autonomy in Data-Driven Medicine

Protecting user rights across genomic and physiological data streams.

TRL
6/9
Impact
4/5
Investment
3/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions